1Department of Endoscopy, Fukuoka University Chikushi Hospital, Fukuoka, Japan
2Department of Human Pathology, Juntendo University Graduate School of Medicine, Tokyo, Japan
3Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan
4Department of Gastroenterology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan
5Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Osaka, Japan
6Department of Pathology, Fukuoka University Chikushi Hospital, Fukuoka, Japan
7Department of Development, FAST Inc., Tokyo, Japan
© 2024 Korean Society of Gastrointestinal Endoscopy
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Conflicts of Interest
The authors have no potential conflicts of interest.
Funding
None.
Acknowledgments
We thank Honyaku Center Inc. for English language editing. The authors received no financial support for this study.
Author Contributions
Conceptualization: KY, NU, HI; Methodology: TY, SN; Project administration: NU, HD, HI; Resources: TY, SN; Software: YT; Writing–original draft: KY; Writing–review & editing: all authors.
E-learning group |
Non-e-learning group |
|||
---|---|---|---|---|
n | Mean±SD (%) | n | Mean±SD (%) | |
Overall | 151 | 1.24±0.26 | 144 | 1.00±0.16a) |
Lower score group | 86 | 1.34±0.29 | 80 | 1.03±0.18a) |
Higher score group | 65 | 1.19±0.14 | 64 | 1.03±0.11a) |
Less experienced group | 84 | 1.28±0.26 | 72 | 0.98±0.17a) |
More experienced group | 67 | 1.19±0.26 | 72 | 1.03±0.14a) |
Asia-Oceania | 32 | 1.33±0.34 | 30 | 1.05±0.17a) |
Europe | 22 | 1.18±0.24 | 21 | 0.94±0.23b) |
Latin America | 97 | 1.23±0.23 | 93 | 1.00±0.13a) |
Adapted from Yao et al. EBioMedicine 2016;9:140–147, according to the Creative Commons license.5
SD, standard deviation.
a) p<0.001 for the e-learning group versus the non-e-learning group.
b) p=0.002 for the e-learning group versus the non-e-learning group.
E-learning group |
Non-e-learning group |
|||
---|---|---|---|---|
n | Mean±SD (%) | n | Mean±SD (%) | |
Overall | 151 | 1.24±0.26 | 144 | 1.00±0.16 |
Lower score group | 86 | 1.34±0.29 | 80 | 1.03±0.18 |
Higher score group | 65 | 1.19±0.14 | 64 | 1.03±0.11 |
Less experienced group | 84 | 1.28±0.26 | 72 | 0.98±0.17 |
More experienced group | 67 | 1.19±0.26 | 72 | 1.03±0.14 |
Asia-Oceania | 32 | 1.33±0.34 | 30 | 1.05±0.17 |
Europe | 22 | 1.18±0.24 | 21 | 0.94±0.23 |
Latin America | 97 | 1.23±0.23 | 93 | 1.00±0.13 |
Adapted from Yao et al. EBioMedicine 2016;9:140–147, according to the Creative Commons license. SD, standard deviation.